• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1

CATEGORIES

  • 11
  • 3
  • 1
  • 1

PRICE

0
9
9
16

PUBLISHED

0
0
0
16

PRODUCT TYPE

16

Search "Sareum Ltd-Deals & Alliances Report" returned 16 results.

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2013

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review,...

August 2013
FROM

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review,...

February 2014
FROM

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2013

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review,...

March 2013
FROM

Intestinal Cancer - Pipeline Review, H2 2012

Intestinal Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Intestinal Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report...

December 2012
FROM

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2012

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review,...

August 2012
FROM

Colorectal Cancer - Pipeline Review, H2 2011

Colorectal Cancer - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Colorectal Cancer - Pipeline Review, H2 2011', provides an overview of the Colorectal Cancer therapeutic pipeline. This...

September 2011
FROM

Colorectal Cancer - Pipeline Review, Q1 2011

Colorectal Cancer - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Colorectal Cancer - Pipeline Review, Q1 2011', provides an overview of the Colorectal Cancer therapeutic pipeline. This...

February 2011
FROM

Multiple Sclerosis - Pipeline Review, H2 2011

Multiple Sclerosis - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Multiple Sclerosis - Pipeline Review, H2 2011', provides an overview of the Multiple Sclerosis therapeutic pipeline....

September 2011
FROM

Colon Cancers - Pipeline Review, Q1 2011

Colon Cancers - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Colon Cancers - Pipeline Review, Q1 2011', provides an overview of the Colon Cancers therapeutic pipeline. This report provides...

February 2011
FROM

Liver Cancer - Pipeline Review, Q3 2011

Liver Cancer - Pipeline Review, Q3 2011 Summary Global Markets Direct’s, 'Liver Cancer - Pipeline Review, Q3 2011', provides an overview of the Liver Cancer therapeutic pipeline. This report provides...

July 2011
FROM

Gastrointestinal Tract Cancer - Pipeline Review, H2 2012

Gastrointestinal Tract Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Gastrointestinal Tract Cancer - Pipeline Review, Global Markets Direct’s, 'Gastrointestinal Tract Cancer...

September 2012
FROM

Melanoma - Pipeline Review, Q4 2010

Melanoma - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Melanoma Pipeline Review, Q4 2010”, provides an overview of the Melanoma therapeutic pipeline. This report provides information...

December 2010
FROM

Melanoma - Pipeline Review, H2 2011

Melanoma - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H2 2011', provides an overview of the Melanoma therapeutic pipeline. This report provides information...

September 2011
FROM

Non-Small Cell Lung Cancer - Pipeline Review, H2 2011

Non-Small Cell Lung Cancer - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Non-Small Cell Lung Cancer - Pipeline Review, H2 2011', provides an overview of the Non-Small Cell Lung Cancer...

September 2011
FROM

Antivirals - Global Strategic Business Report

This report analyzes the worldwide markets for Antivirals in US$ Million The major product segments analyzed are HIV Antivirals (Reverse Transcriptase Inhibitors (RTIs) (Nucleotide Reverse Transcriptase...

October 2006
FROM

Leukemias - Pipeline Review, H1 2012

Leukemias – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Leukemias - Pipeline Review, H1 2012', provides an overview of the Leukemias therapeutic pipeline. This report provides information...

January 2012
FROM
Loading Indicator

Our Clients

Walgreen's Company Elanco Global Nu Skin Enterprises Kemin Industries, Inc. Suan Farma Inc. Metagenics, Inc.